Nomic logo

Nomic

Nomic develops a proteomic technology platform to understand, detect, and treat diseases with DNA nanotechnology.

2

Funding Rounds

$59.0m

Money raised

Overview

Nomic develops a proteomic technology platform to understand, detect, and treat diseases with DNA nanotechnology.

Funding

Funding series

Funding Series Analysis

The company Nomic has raised a total of $59m in funding over 2 rounds.

Key Insights:

  • Nomic September 2024 Series B Funding Round: $42m
  • Nomic Bio Series A round, December 2021: $17m
Nomic logo
Nomic September 2024 Series B Funding Round $42m
Nomic logo
Nomic Bio Series A round, December 2021 $17m

Industries

Nomic is active in the following industries: